MedTrace Logo

Dietary Supplement on the Intestinal Microbiota in Patients with Colon Cancer

NCT05472753 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-02-12

No results posted yet for this study

Summary

Effect of a dietary supplement with antioxidant and anti-inflamatory properties on the intestinal microbiota in patients with colon cancer. Ramdonized placebo controlled clinical trial. Teratrophic study

Conditions

Interventions

DIETARY_SUPPLEMENT

Experimental Treatment, DCOOP Product, Hydroxytyrosol extract

Intervention group will receive a nutritional formula from DCOOP (Spain).

DIETARY_SUPPLEMENT

Experimental Treatment,Indukern product, Curcumin and selenium extract

Intervention group will receive a nutritional formula from Indukern (Spain).

OTHER

Control Treatment

Control group will receive a placebo (product loading substance)

Sponsors & Collaborators

  • Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

    lead OTHER

Principal Investigators

  • Gabriel Olveira Fuster, MD, PhD. · Hospital Regional Universitario de Málaga, FIMABIS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-16
Primary Completion
2024-02-27
Completion
2024-05-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05472753 on ClinicalTrials.gov